Exchange Traded Concepts, LLC Ligand Pharmaceuticals Inc Transaction History
Exchange Traded Concepts, LLC
- $4.74 Billion
- Q4 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 83 shares of LGND stock, worth $10,015. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83Holding current value
$10,015% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
275Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$347 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$252 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$122 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$107 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$89.7 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.04B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...